FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.39), $0.01 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $2.34 million versus the consensus estimate of $2.27 million.
"Our first quarter got off to a solid start, as sales, new contracts, and go-lives... More

